Craig Thompson
CEO
Management
Anthera Pharmaceuticals
United States of America
Biography
Craig joined Anthera as President & Chief Operating Officer in January 2016 and became Chief Executive Officer in November 2016. Prior to Anthera, Craig was the Chief Operating Officer for Tetraphase Pharmaceuticals. Prior to Tetraphase, Craig served as Chief Commercial Officer for Trius Therapeutics through the acquisition of Trius by Cubist Pharmaceuticals. Prior to Trius, Craig served in various global and U.S. commercial roles at Pfizer Inc. from 2003 to December 2010 ultimately serving as Vice President of Marketing for Pfizer’s Specialty Care Business Unit. From 1992 to 2003, Craig served in positions of increasing responsibility at Merck & Co., Inc
Research Interest
Management
